Sifan Guo
Haikou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Babaodan Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease with Co-Modulation of FXR, NF-κB, and SLC22A7 in Bile Acid Metabolism.
Journal: Journal of ethnopharmacology
Published: April 06, 2026
Babaodan alleviates MAFLD through hepatic glycerophospholipid metabolism and PPARγ/RXRA/GPAT3 based on spatial metabolomics and proteomics analysis.
Journal: Journal of ethnopharmacology
Published: January 12, 2026
MAPK14/SLC7A11/GPX4 axis dysregulation drives podocyte ferroptosis via mediating glycerophospholipid metabolism.
Journal: Cell death discovery
Published: October 14, 2025
Spatial atlas of human diabetic kidney uncovered podocyte-driven metabolic-inflammatory crosstalk via glycerolipid reprogramming and DUSP4/MMP3 axis.
Journal: Fundamental research
Published: September 08, 2025
Spatial Metabolomics Identifies Riboflavin Metabolism as a Therapeutic Target of Huangqi Guizhi Wuwu Decoction in Diabetic Nephropathy.
Journal: Biomedical chromatography : BMC
Published: June 11, 2025
Integrated Omics Reveal Dendrobium nobile Lindl.'s Anti-Diabetic Mechanisms via Arginine/Proline and Glycerophospholipid Pathways.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 29, 2025
Single cell sequencing and spatial multiomics of diabetic kidney segmentation insights zonation-specific therapeutic metabolic pathways.
Journal: Cell insight
Published: March 18, 2025
Spatially segregated multiomics decodes metformin-mediated function-specific metabolic characteristics in diabetic kidney disease.
Journal: Life metabolism
Published: February 03, 2025
Integrated Metabolomics and Proteomics to Decipher Simiao Pill Improving Lipid Homeostasis through PTGES3-mediated Arachidonic Acid Metabolism in AIA Model.
Journal: Current pharmaceutical design
Published: December 12, 2024
Proteomics exploration of metformin hydrochloride for diabetic kidney disease treatment via the butanoate metabolism pathway.
Journal: Journal of pharmaceutical and biomedical analysis
Published: September 06, 2024
The metformin mediated MAPK signaling pathway influences D-Xylose regulation during diabetic kidney disease therapy.
Journal: Communications medicine
Published: September 05, 2024
Last Updated: 09/26/2026